The bio sector is littered with Phase 1, 2 & 3 trials where...

The bio sector is littered with Phase 1, 2 & 3 trials where companies have spent millions of $ and failed to take the product to the next stage or commercialised.
Just because we have Professor Fraser and his team working on this guarantees nothing and they might have a far greater understanding of how they expect the vac to work, but they don't know the results until they are released to them.

I think AHZ has amazing products but let's keep it real, getting the vac to market is still a long shot. For me that's the chance of blue sky but I'm here for adapt.